Biotechnology AXSM ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 12, 2022 in the Class Action Filed on Behalf of Axsome Therapeutics, Inc. Shareholders May 24, 2022
Biotechnology Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Axsome Therapeutics, Inc. (AXSM) Investors of Class Action and Encourages Investors to Contact the Firm May 23, 2022
Biotechnology Positive Results from VISEN’s Phase 3 Trial of Once-Weekly TransCon hGH in China Consistent with Ascendis Pharma’s Phase 3 Height Trial May 23, 2022
Biotechnology Ascendis Pharma A/S Announces New Commercial Endocrinology Leadership Appointments May 23, 2022
Biotechnology US FDA Accepts for Review Biohaven’s New Drug Application (NDA) Filing of Intranasal Zavegepant for the Acute Treatment of Migraine May 23, 2022
Search
biotech stock market
